Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ISEE | AMGN | VRTX | REGN | GILD |
| Company | Iveric Bio Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 39.86 | 333.23 | 497.00 | 1,075.35 | 72.89 |
| High | 39.99 | 336.35 | 498.77 | 1,078.71 | 73.32 |
| Low | 39.85 | 332.47 | 491.52 | 1,064.95 | 72.02 |
| Last | 39.95 | 334.40 | 495.59 | 1,073.05 | 72.23 |
| Change | +0.15 | +3.11 | +4.02 | +9.45 | -0.33 |
| % Change | +0.38% | +0.94% | +0.82% | +0.89% | -0.45% |
| Volume | 10,999,100 | 651,571 | 451,423 | 109,455 | 1,625,965 |
| 20-Day Average Volume | 5,716,510 | 2,032,076 | 1,112,564 | 416,105 | 6,310,956 |
| Previous Close | 39.80 | 331.29 | 491.57 | 1,063.60 | 72.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 39.01 | 320.98 | 481.85 | 1,064.51 | 69.79 |
| 20-Day Raw Stochastic | 98.96% | 87.83% | 87.91% | 64.60% | 72.73% |
| 20-Day Relative Strength | 69.12% | 68.02% | 67.15% | 58.48% | 62.99% |
| Weighted Alpha | +139.70 | +41.51 | +43.88 | +42.88 | -4.66 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 64% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.55% since 06/30/23 | +1.46% since 07/15/24 | +0.81% since 07/15/24 | -0.87% since 07/15/24 | +2.37% since 07/15/24 |
| Low | 39.34 on 07/03/23 | 328.00 on 07/16/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.33 on 07/16/24 |
| High | 39.99 on 07/10/23 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
| 1-Month | |||||
| %Chg | +4.80% since 06/09/23 | +8.70% since 06/21/24 | +5.57% since 06/21/24 | +1.86% since 06/21/24 | +2.58% since 06/21/24 |
| Low | 36.15 on 06/28/23 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 39.99 on 07/10/23 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 3-Month | |||||
| %Chg | +46.66% since 04/10/23 | +23.20% since 04/22/24 | +23.73% since 04/22/24 | +19.17% since 04/22/24 | +8.27% since 04/22/24 |
| Low | 27.23 on 04/11/23 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 39.99 on 07/10/23 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 6-Month | |||||
| %Chg | +113.98% since 01/10/23 | +8.00% since 01/22/24 | +12.43% since 01/22/24 | +13.78% since 01/22/24 | -7.57% since 01/22/24 |
| Low | 18.25 on 01/11/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 39.99 on 07/10/23 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,504,431 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
| Shares Outstanding, K | 137,783 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -185,210,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -72,230,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 1.07 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.53 on 05/10/23 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 07/25/23 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |